Vulnerability in Oracle Pharmaceutical
CVE-2006-5374
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
Published · last modified .
CVSS v2 metric
CVSS v2 base score 10.0 (High). Vector: AV:N/AC:L/Au:N/C:C/I:C/A:C. This CVE predates CVSS v3 and has no v3 score from NVD.
EPSS exploit prediction
EPSS: 0.042 (90.6th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 91st percentile — 90.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.041 · newest: 0.042 · change: +0.000
Affected products
- Oracle Pharmaceutical — versions 4.5.1
References
- www.red-database-security.com/advisory/oracle_cpu_oct_2006.html
- www.securityfocus.com/bid/20588 (Patch, vdb-entry)
- www.securityfocus.com/archive/1/449711/100/0/threaded (vendor-advisory)
- www.oracle.com/technetwork/topics/security/cpuoct2006-095368.html
- www.vupen.com/english/advisories/2006/4065 (vdb-entry)
- secunia.com/advisories/22396 (third-party-advisory)
- securitytracker.com/id (vdb-entry)
- www.us-cert.gov/cas/techalerts/TA06-291A.html (US Government Resource, third-party-advisory)